Literature DB >> 8820962

Natural immunodominant and experimental autoimmune encephalomyelitis-protective determinants within the Lewis rat V beta 8.2 sequence include CDR2 and framework 3 idiotopes.

M Vainiene1, B Celnik, A A Vandenbark, G A Hashim, H Offner.   

Abstract

The V beta 8.2-39-59 peptide has served as a prototypic natural regulatory idiotope in Lewis rats developing experimental autoimmune encephalomyelitis (EAE). The purpose of the present study was to determine if additional regulatory regions were contained within the V beta 8.2 sequence expressed by most encephalogenic T cells. A comprehensive strategy utilizing V beta 8+ hybridomas, a recombinant (r) V beta 8.2 molecule, and overlapping synthetic V beta 8.2 peptides reconfirmed the natural recognition of the 39-59 idiotope, and revealed a second immunodominant and EAE-protective determinant residing within residues 71-90. Both the V beta 8.2-39-59 and V beta 8.2-71-90 peptides were immunogenic, and each was recognized after immunization of Lewis rats with V beta 8+ cells or rV beta 8.2, indicating the preservation of these epitopes during the processing of the V beta 8.2 chain. Moreover, both epitopes were recognized naturally by T cells from rats developing or recovering from EAE that had never been purposefully immunized with V beta 8.2 peptides or rV beta 8.2. Of additional interest, the V beta 8.2-31-50 peptide was recognized by T cells from some rats immunized with complete Freund's adjuvant (CFA) alone. This peptide possessed mildly protective activity against EAE and thus could account for sporadic reports of CFA interference in EAE.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8820962     DOI: 10.1002/(SICI)1097-4547(19960115)43:2<137::AID-JNR2>3.0.CO;2-H

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  4 in total

1.  Treatments targeting the T cell receptor (TCR): effects of TCR peptide-specific T cells on activation, migration, and encephalitogenicity of myelin basic protein-specific T cells.

Authors:  H Offner; R Jacobs; B F Bebo; A A Vandenbark
Journal:  Springer Semin Immunopathol       Date:  1999

Review 2.  TCR peptide therapy in human autoimmune diseases.

Authors:  A A Vandenbark; E Morgan; R Bartholomew; D Bourdette; R Whitham; D Carlo; D Gold; G Hashim; H Offner
Journal:  Neurochem Res       Date:  2001-06       Impact factor: 3.996

3.  Prevention and treatment of experimental autoimmune encephalomyelitis with clonotypic CDR3 peptides: CD4(+) Foxp3(+) T-regulatory cells suppress interleukin-2-dependent expansion of myelin basic protein-specific T cells.

Authors:  Abigail C Buenafe; Shayne Andrew; Michael Afentoulis; Halina Offner; Arthur A Vandenbark
Journal:  Immunology       Date:  2010-01-06       Impact factor: 7.397

4.  Regulatory T cells specific for the same framework 3 region of the Vbeta8.2 chain are involved in the control of collagen II-induced arthritis and experimental autoimmune encephalomyelitis.

Authors:  V Kumar; F Aziz; E Sercarz; A Miller
Journal:  J Exp Med       Date:  1997-05-19       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.